Health care expenditure on schizophrenia patients in Belgium

Schizophrenia Bulletin

Volumn 24, Issue 4, 1998, Pages 519-527

  De Hert, Marc ^a,b   Thys, Erik ^a   Boydens, Joel ^c   Gilis, Pierre ^d   Kesteloot, Katrien ^e   Verhaegen, Lydwine ^f   Peuskens, Jozef ^a,e  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Brussels Nighthospital   (Belgium)

^c National Alliance of Christian Mutualities   (Belgium)

^d Eli Lilly Benelux   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f Catholic University ^*

Author keywords

Costs; Economic evaluation; Epidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

BELGIUM; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG COST; EMPLOYMENT; FAMILY HISTORY; FEMALE; GOVERNMENT; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 0031756193     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033346     Document Type: Conference Paper

References (30)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: The Association, 1987.
2. Andreasen, N.C. Assessment issues and the cost of schizophrenia. Schizophrenia Bulletin, 17(3):475-481, 1991.
3. Andrews, G.; Hall, W.; Goldstein, G.; Lapsley, H.; Bartels, R.; and Silove, D. The economic cost of schizophrenia. Archives of General Psychiatry, 42:537-544, 1985.
4. Davies, L.M., and Drummond, M.F. Economics and schizophrenia: The real cost. British Journal of Psychiatry, 165(Suppl. 25):18-21, 1994.
5. De Hert, M.; McKenzie, K.; Pieters, G.; Vercruyssen, V.; and Peuskens, J. Developments in the care for chronic patients in Belgium. International Journal of Mental Health, 26(2):86-97, 1997.
6. De Hert, M., and Peuskens, J. Suicide in schizophrenia. Acta Psychiatrica Belgica, Suppl. I:37-45, 1998.
7. De Hert, M.; Thys, E.; and Peuskens, J. The costs of schizophrenia. Acta Psychiatrica Belgica, Suppl. I:9-16, 1998.
8. De Hert, M.; Thys, E.; Vercruyssen, V.; and Peuskens, J. Partial hospitalization at night, the Brussels Nighthospital. Psychiatric Services, 47:527-528, 1996.
9. Evers, S.M.A.A., and Ament, J.H.A. Costs of schizophrenia in The Netherlands. Schizophrenia Bulletin, 21(1):141-153, 1995.
10. Fischer, W., and Barrelet, L. Les coûts des traitements psychiatriques: Une approche comparative de trois catégories de patients. Médecine Sociale et Preventive, 32:168-175, 1987.
11. Guest, J.F.; Hart, W.M.; Cookson, R.F.; and Lindström, E. Pharmacoeconomic evaluation of long-term treatment with risperidone for patients with chronic schizophrenia. British Journal of Medical Economics, 10:59-67, 1996.
12. Hall, W.; Goldstein, G.; Andrews, G.; Lapsley, H.; Bartels, R.; and Silove, D. Estimating the economic costs of schizophrenia. Schizophrenia Bulletin, 11(4):598-610, 1985.
13. Hu, T.W.; Shumway, M.; and Hargreaves, W.A. Estimating costs of schizophrenia and its treatment. In: Moscarelli, M.; Rupp, A.; and Sartorius, N., eds. Handbook of Mental Health Economics and Health Policy. Vol. 1. Schizophrenia. Chichester, England: John Wiley & Sons, 1996. pp. 359-371.
14. Jones, H.J.; Thornicroft, G.; Coffey, M.; and Dunn, G. A brief health outcome scale: Reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry, 166:654-659, 1995.
15. Kavanagh, S.; Opit, L.; Knapp, M.; and Beecham, J. Schizophrenia: Shifting the balance of care. Social Psychiatry and Psychiatric Epidemiology, 30:206-212, 1995.
16. Lindström, E. The hidden burden of schizophrenia. Journal of Drug Development, 7(4):281-288, 1996.
17. Lindström, E.; Erikson, B.; Hellgren, A.; von Knorring, H.; and Eberhard, G. Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia. Clinical Therapeutics, 17:402-412, 1995.
18. Lins, R.L.; Daelemans, R.; and Bussels, J. Gezondheidseconomische Aspecten van Cardiovasculaire Ziekten. Tijdschrift voor Geneeskunde, 51(10):727-734, 1995.
19. Lund, P. "A Calculation of the Costs of Schizophrenia in Denmark." Paper presented at the A.R.C.A.P. Third Workshop on Costs and Assessment in Psychiatry, Venice, October 28-30, 1994.
20. Meltzer, H.Y.; Cola, P.; Way, L.; Thompson, P.A.; Bastani, B.; Davies, M.A.; and Snitz, B. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry, 150:1630-1638, 1993.
21. Peuskens, J. Proper psychosocial rehabilitation of stabilized patients with schizophrenia: The role of new therapies. European Neuropsychopharmacology, 6:7-12, 1996.
22. Peuskens, J., and De Hert, M., eds. Good Medical Practice in the Use of Antipsychotics. Brussels, Belgium: Lundbeck, 1997.
23. Peuskens, J.; De Hert, M.; Cosyns, P.; Pieters, G.; Theys, P.; and Vermote, R. Suicide in young schizophrenic patients during and after inpatient stay. International Journal of Mental Health, 25(4):39-44, 1996.
24. Rice, D.P., and Miller, L.S. The economic burden of schizophrenia: Conceptual and methodological issues and cost estimates. In: Moscarelli, M.; Rupp, A.; and Sartorius, N., eds. Handbook of Mental Health Economics and Health Policy. Vol. 1. Schizophrenia. Chichester, England: John Wiley & Sons, 1996. pp. 321-334.
25. Rosenheck, R.; Neale, M.; Leaf, P.; Milstein, R.; and Frisman, L. Multisite experimental cost study of intensive psychiatric community care. Schizophrenia Bulletin, 21(1):129-140, 1995.
26. Rupp, A., and Keith, S.J. The costs of schizophrenia. Psychiatric Clinics of North America, 16(2):413-423, 1993.
27. Salize, H.J., and Rössler, W. The cost of comprehensive care of people with schizophrenia in the community. British Journal of Psychiatry, 169:42-48, 1996.
28. Westermeyer, J.K., and Harrow, M. Course and outcome in schizophrenia. In: Tsuang, M., and Simpson, J.C., eds. Handbook of Schizophrenia. Vol. 3. Amsterdam, Netherlands: Elsevier Science Publishers, 1988. pp. 205-244.
29. Wiersma, D.; Kluiter, H.; Nienhuis, F.J.; Rüphan, M.; and Giel, R. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders. British Journal of Psychiatry, 166(Suppl. 27):52-59, 1995.
30. Wistedt, B. In: Michels, R., ed. The Cost of Schizophrenia. London, England: Royal Society of Medicine Services, 1992. pp. 3-5.